Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peanut Hypersensitivity | 7 | 2023 | 157 | 2.830 |
Why?
|
| Food Hypersensitivity | 7 | 2023 | 628 | 2.310 |
Why?
|
| Desensitization, Immunologic | 9 | 2023 | 490 | 2.170 |
Why?
|
| 2S Albumins, Plant | 4 | 2019 | 23 | 2.050 |
Why?
|
| Antigens, Plant | 4 | 2019 | 84 | 2.000 |
Why?
|
| Basophil Degranulation Test | 3 | 2019 | 16 | 1.950 |
Why?
|
| Basophils | 4 | 2021 | 400 | 1.900 |
Why?
|
| Immunoglobulin E | 9 | 2023 | 1497 | 1.040 |
Why?
|
| Immunologic Tests | 1 | 2019 | 102 | 0.720 |
Why?
|
| Glycoproteins | 2 | 2015 | 2318 | 0.590 |
Why?
|
| Allergens | 7 | 2023 | 1292 | 0.590 |
Why?
|
| B-Lymphocytes | 3 | 2019 | 4926 | 0.550 |
Why?
|
| Drug Hypersensitivity | 4 | 2017 | 868 | 0.450 |
Why?
|
| Carboplatin | 2 | 2015 | 807 | 0.450 |
Why?
|
| Skin Tests | 4 | 2020 | 644 | 0.450 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2017 | 332 | 0.390 |
Why?
|
| Vaccines | 1 | 2018 | 735 | 0.380 |
Why?
|
| Flow Cytometry | 1 | 2017 | 6132 | 0.290 |
Why?
|
| Eosinophils | 1 | 2010 | 937 | 0.280 |
Why?
|
| Th2 Cells | 2 | 2020 | 1058 | 0.270 |
Why?
|
| Epitopes | 2 | 2023 | 2657 | 0.230 |
Why?
|
| Administration, Oral | 3 | 2019 | 3963 | 0.210 |
Why?
|
| Retinal Dehydrogenase | 1 | 2020 | 74 | 0.210 |
Why?
|
| Immunologic Memory | 2 | 2019 | 1382 | 0.200 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2020 | 179 | 0.190 |
Why?
|
| Enterocolitis | 1 | 2020 | 93 | 0.180 |
Why?
|
| Antigen-Presenting Cells | 1 | 2020 | 985 | 0.150 |
Why?
|
| Algorithms | 1 | 2017 | 13718 | 0.150 |
Why?
|
| Biotechnology | 1 | 2018 | 279 | 0.150 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 574 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 812 | 0.140 |
Why?
|
| Receptors, IgE | 2 | 2020 | 405 | 0.140 |
Why?
|
| False Negative Reactions | 2 | 2015 | 605 | 0.130 |
Why?
|
| Dietary Proteins | 1 | 2020 | 971 | 0.130 |
Why?
|
| Hypersensitivity | 2 | 2020 | 1040 | 0.120 |
Why?
|
| Organoplatinum Compounds | 1 | 2015 | 430 | 0.120 |
Why?
|
| Anaphylaxis | 2 | 2020 | 752 | 0.120 |
Why?
|
| Humans | 25 | 2023 | 717237 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 1836 | 0.120 |
Why?
|
| Child | 7 | 2020 | 74387 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 616 | 0.120 |
Why?
|
| Histamine Release | 1 | 2012 | 152 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2021 | 2332 | 0.110 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2012 | 394 | 0.110 |
Why?
|
| Clone Cells | 1 | 2015 | 1760 | 0.110 |
Why?
|
| Asthma | 1 | 2010 | 5940 | 0.110 |
Why?
|
| Mast Cells | 1 | 2019 | 1609 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2015 | 1423 | 0.100 |
Why?
|
| Bronchial Provocation Tests | 1 | 2010 | 227 | 0.100 |
Why?
|
| Antibodies | 1 | 2018 | 2442 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 9577 | 0.100 |
Why?
|
| Breath Tests | 1 | 2010 | 288 | 0.090 |
Why?
|
| Adolescent | 6 | 2020 | 85139 | 0.090 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2010 | 317 | 0.090 |
Why?
|
| Vancomycin | 1 | 2012 | 503 | 0.090 |
Why?
|
| Sputum | 1 | 2010 | 474 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 5891 | 0.080 |
Why?
|
| Receptors, IgG | 1 | 2012 | 611 | 0.080 |
Why?
|
| Exanthema | 1 | 2012 | 462 | 0.080 |
Why?
|
| Eosinophilia | 1 | 2012 | 513 | 0.080 |
Why?
|
| Male | 15 | 2020 | 351380 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2020 | 20095 | 0.070 |
Why?
|
| Bronchi | 1 | 2010 | 847 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1920 | 0.070 |
Why?
|
| Computational Biology | 1 | 2018 | 3568 | 0.070 |
Why?
|
| Animals | 9 | 2020 | 170890 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2020 | 41221 | 0.070 |
Why?
|
| Cytokines | 1 | 2019 | 7223 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14903 | 0.060 |
Why?
|
| Tunica Intima | 1 | 2006 | 501 | 0.060 |
Why?
|
| Infant | 3 | 2020 | 34574 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2006 | 671 | 0.060 |
Why?
|
| Risk | 2 | 2015 | 9773 | 0.060 |
Why?
|
| HIV Infections | 2 | 2019 | 15672 | 0.060 |
Why?
|
| Female | 11 | 2020 | 377909 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9597 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 62348 | 0.050 |
Why?
|
| Femoral Artery | 1 | 2006 | 922 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 384 | 0.050 |
Why?
|
| Syndrome | 2 | 2020 | 3201 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2020 | 206 | 0.050 |
Why?
|
| Emollients | 1 | 2019 | 30 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 4486 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2002 | 864 | 0.050 |
Why?
|
| Cell Degranulation | 1 | 2020 | 297 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2011 | 2988 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10802 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2019 | 195 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29226 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 2114 | 0.040 |
Why?
|
| Mitochondrial Proteins | 2 | 2002 | 991 | 0.040 |
Why?
|
| Biopsy | 1 | 2010 | 6753 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3433 | 0.040 |
Why?
|
| Tretinoin | 1 | 2020 | 530 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2012 | 11910 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2020 | 535 | 0.040 |
Why?
|
| Stem Cells | 1 | 2011 | 3597 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 1276 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 1138 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2002 | 4993 | 0.040 |
Why?
|
| Middle Aged | 8 | 2020 | 215041 | 0.030 |
Why?
|
| Monocytes | 2 | 2020 | 2657 | 0.030 |
Why?
|
| Inflammation | 2 | 2017 | 10116 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2001 | 1024 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2002 | 1750 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13754 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7074 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7486 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2012 | 431 | 0.030 |
Why?
|
| Herpesvirus 6, Human | 1 | 2012 | 92 | 0.030 |
Why?
|
| Nephritis | 1 | 2012 | 159 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4329 | 0.030 |
Why?
|
| Myocardium | 2 | 2002 | 4943 | 0.030 |
Why?
|
| Hepatitis | 1 | 2012 | 213 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2002 | 5135 | 0.020 |
Why?
|
| Lymphatic Diseases | 1 | 2012 | 331 | 0.020 |
Why?
|
| Weight Gain | 1 | 2020 | 2209 | 0.020 |
Why?
|
| Tachycardia | 1 | 2012 | 609 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2731 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56247 | 0.020 |
Why?
|
| Adult | 6 | 2020 | 212451 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 20568 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4381 | 0.020 |
Why?
|
| Ion Channels | 2 | 2002 | 1085 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9407 | 0.020 |
Why?
|
| Proteins | 1 | 2001 | 6166 | 0.020 |
Why?
|
| Platelet Function Tests | 1 | 2006 | 267 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2002 | 12073 | 0.020 |
Why?
|
| Fever | 1 | 2012 | 1590 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 16693 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 162856 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 12433 | 0.020 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2002 | 61 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2006 | 1173 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11758 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2002 | 51 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 2002 | 138 | 0.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2002 | 83 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8749 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21805 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 735 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2001 | 47 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2001 | 137 | 0.010 |
Why?
|
| Mice | 3 | 2020 | 81126 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2020 | 24742 | 0.010 |
Why?
|
| Obesity | 1 | 2002 | 12247 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 72614 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1621 | 0.010 |
Why?
|
| Thinness | 1 | 2002 | 489 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4735 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 4636 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2001 | 958 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 1812 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2002 | 1649 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 2336 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 13274 | 0.010 |
Why?
|
| Fasting | 1 | 2002 | 1622 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2002 | 1933 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 1684 | 0.010 |
Why?
|
| Rats | 2 | 2002 | 25091 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58528 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2001 | 1234 | 0.010 |
Why?
|
| Cell Movement | 1 | 2006 | 5465 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 2416 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 2001 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 70864 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2001 | 2049 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 2748 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 15258 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8600 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4480 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2001 | 2974 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7952 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2001 | 3083 | 0.010 |
Why?
|
| Heart | 1 | 2001 | 4332 | 0.010 |
Why?
|
| Mitochondria | 1 | 2001 | 3641 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 9804 | 0.000 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_